Pasithea Therapeutics Corp.
KTTA
$0.956
$0.095411.09%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 1.75M | 1.42M | 1.59M | 2.29M | 1.80M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 3.26M | 3.00M | 3.95M | 4.04M | 5.15M |
Operating Income | -3.26M | -3.00M | -3.95M | -4.04M | -5.15M |
Income Before Tax | -3.18M | -3.00M | -3.87M | -3.86M | -5.03M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -3.18M | -3.00M | -3.87M | -3.86M | -5.03M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -16.90K |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -3.18M | -3.00M | -3.87M | -3.86M | -5.05M |
EBIT | -3.26M | -3.00M | -3.95M | -4.04M | -5.15M |
EBITDA | -3.10M | -2.84M | -3.78M | -3.88M | -4.99M |
EPS Basic | -2.53 | -2.87 | -3.71 | -3.70 | -4.55 |
Normalized Basic EPS | -1.58 | -1.80 | -2.32 | -2.31 | -2.82 |
EPS Diluted | -2.53 | -2.87 | -3.71 | -3.70 | -4.55 |
Normalized Diluted EPS | -1.58 | -1.80 | -2.32 | -2.31 | -2.82 |
Average Basic Shares Outstanding | 1.25M | 1.04M | 1.04M | 1.04M | 1.23M |
Average Diluted Shares Outstanding | 1.25M | 1.04M | 1.04M | 1.04M | 1.23M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |